AVE 4F SiteSeer Cardiovascular Angiographic Catheter
by Arterial Vascular Engineering, Inc.
510(k) K984627
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK984627 | Date27 Jul 1999 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DQO
- Device Class
- Class II
- Regulation
- 21 CFR Part 870.1200
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The AVE 4F SiteSeer Cardiovascular Angiographic Catheter is an intravascular diagnostic catheter used in the cardiovascular system. It functions by being inserted into the heart and vessels to record intracardiac pressures, sample blood, and deliver substances such as radiopaque contrast media.
This device is supplied as a sterile, single-use catheter and is classified as a Class II medical device under product code DQO. It received FDA 510(k) clearance (K984627) on July 27, 1999, and is substantially equivalent to a predicate device. The catheter is intended for use in cardiovascular diagnostic procedures and is manufactured by Arterial Vascular Engineering, Inc. in Billerica, Massachusetts.
Other devices from Arterial Vascular Engineering, Inc.
Questions
AI-generated answers, 1 Oct 2026
What is the AVE 4F SiteSeer Cardiovascular Angiographic Catheter used for?
It is used to record intracardiac pressures, sample blood, and deliver radiopaque contrast media during cardiovascular diagnostic procedures by being inserted into the heart and blood vessels.
Is the AVE 4F SiteSeer catheter sterile and single-use?
Yes, the device is supplied as a sterile, single-use catheter, meaning it is intended for one procedure only and should not be reprocessed or reused to maintain sterility and patient safety.
What regulatory pathway was used for the AVE 4F SiteSeer catheter?
The device received FDA 510(k) clearance under K984627 on July 27, 1999, and was determined to be substantially equivalent to a predicate device, which is the standard pathway for moderate-risk Class II devices.